Product Information
Contents: Cy5 anti-mouse CD8a (Ly-2)
Catalog Number: 19-0081
Sizes: 50 ug, 100 ug, 200 ug
Formulation: Phosphate buffer pH 7.2, 150 mM NaCl, 0.09% NaN3
Storage Conditions: Store at 4°C. DO NOT FREEZE. LIGHT-SENSITIVE MATERIAL.
Clone: 53-6.7
Isotype: Rat IgG2a, κ
|
|
Surface staining of mouse splenocytes with anti-mouse CD8a (53-6.7) FITC (left), and APC (right). Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis.
|
| Available Formats of This Product |
| Cat. No. |
Format |
Excite (nm) |
Emit (nm) |
Reported Applications |
| 14-0081 |
Affinity Purified anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
N/A |
N/A |
FC
IH/F
IP
|
| 16-0081 |
Functional Grade* Purified anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
N/A |
N/A |
FA
FC
|
| 13-0081 |
Biotin anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
N/A |
N/A |
FC
|
| 11-0081 |
FITC anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
488 |
518 |
FC
|
| 12-0081 |
PE anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
488 |
575 |
FC
|
| 15-0081 |
PE-Cy5 anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
488 |
670 |
FC
|
| 17-0081 |
APC anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
633 |
660 |
FC
|
| 19-0081 |
Cy5 anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
633 |
670 |
FC
|
| 25-0081 |
PE-Cy7 anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
488 |
760 |
FC
|
| 36-0081 |
Functional Grade* Biotin anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
N/A |
N/A |
FC
IH/F
|
| 51-0081 |
Alexa Fluor® 647 anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
633 |
668 |
FC
|
| 53-0081 |
Alexa Fluor® 488 anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
488 |
519 |
FC
|
| 56-0081 |
Alexa Fluor® 700 anti-mouse CD8 (alpha subunit, CD8a, Ly-2) (APC-Cy5.5 Equivalent) |
633 |
723 |
FC
|
| 57-0081 |
Pacific Blue® anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
402 |
421 |
FC
|
| 27-0081 |
Allophycocyanin-Alexa Fluor® 750 (APC-Alexa Fluor® 750) anti-mouse CD8 (alpha subunit, CD8a, Ly-2) (APC-Cy7 Equivalent) |
633 |
779 |
FC
|
| 45-0081 |
PerCP-Cy5.5 anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
488 |
690 |
FC
|
| 93-0081 |
eFluorTM 605NC anti-mouse CD8 (alpha subunit, CD8a, Ly-2) |
350-500 |
605 |
FC
|
| 47-0081 |
Allophycocyanin-eFluorTM 780 anti-mouse CD8 (alpha subunit, CD8a, Ly-2) (APC-Alexa Fluor® 750 replacement) |
633 |
780 |
FC
|
| 48-0081 |
eFluorTM 450 anti-mouse CD8 (alpha subunit, CD8a, Ly-2) (Pacific Blue® replacement) |
405 |
450 |
FC
|
*Functional Grade™ (FG™) Purified: Azide-free, sterile-filtered, and endotoxin < 0.001 ng/µg (unless otherwise noted). *Functional Grade™ (FG™) Biotin: Azide-free, sterile-filtered, and endotoxin < 0.05 ng/µg. Purified: Contains azide, not sterile-filtered, and not endotoxin tested. |
Questions? Please consult our answers to frequently asked questions at
http://www.ebioscience.com/faq.
Description
The 53-6.7 monoclonal antibody reacts with the mouse CD8a molecule. CD8a is an approximately 32-34 kDa cell surface receptor expressed either as a heterodimer with the CD8 β chain (CD8 αβ) or as a homodimer (CD8 αα). A majority of thymocytes and a subpopulation of mature αβ TCR T cells express CD8 αβ while γδ TCR T cells, a subpopulation of intestinal intraepithelial lymphocytes (IELs) and dendritic cells express CD8 αα. CD8 binds to MHC class I and through its association with protein tyrosine kinase p56lck plays a role in T cell development and activation of mature T cells.
Applications Reported
For research use only, not for diagnostic or therapeutic use. The 53-6.7 antibody has been reported for use in flow cytometric analysis.
Applications Tested
The 53-6.7 antibody has been tested by flow cytometric analysis of mouse thymocyte and splenocyte suspensions. This can be used at less than or equal to 0.25 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.
References
Mochimaru H, Usui T, Yaguchi T, Nagahama Y, Hasegawa G, Usui Y, Shimmura S, Tsubota K, Amano S, Kawakami Y, Ishida S. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2. Invest Ophthalmol Vis Sci. 2008 May;49(5):2172-7. (
53-6.7, in vivo depletion,
PubMed)
Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, Marshall MA, French BA, Linden J. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation. 2006 Nov 7;114(19):2056-64. (
53-6.7, in vivo depletion,
PubMed)
Taylor JL, Ordway DJ, Troudt J, Gonzalez-Juarrero M, Basaraba RJ, Orme IM. Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA. Infect Immun. 2005 Aug;73(8):5189-93. (
53-6.7, IHC frozen)
Grabbe S, Varga G, Beissert S, Steinert M, Pendl G, Seeliger S, Bloch W, Peters T, Schwarz T, Sunderkötter C, Scharffetter-Kochanek K. Beta2 integrins are required for skin homing of primed T cells but not for priming naďve T cells. J Clin Invest. 2002 Jan;109(2):183-92. (
53-6.7, IHC frozen)
Ledbetter JA, Rouse RV, Micklem HS, Herzenberg LA. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med. 1980 Aug 1;152(2):280-95.
Ledbetter, J. A. and L. A. Herzenberg. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev. 1979;47:63-90.
Related Products
Cat.
19-4321 Cy5 Rat IgG2a Isotype Control
FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT
FOR THERAPEUTIC OR IN VIVO APLICATIONS.
OTHER USE NEEDS LICENSE FROM AMERSHAM PHARMACIA BIOTECH INC. UNDER
U.S. PATENT Nos. 4,981,977 AND 5,268,486 AND OTHER PATENTS PENDING.
THIS MATERIAL IS SUBJECT TO PROPRIETARY RIGHTS OF AMERSHAM PHARMACIA BIOTECH INC.
AND CARNEGIE MELLON UNIVERSITY AND MADE AND SOLD UNDER LICENSE FROM AMERSHAM
PHARMACIA BIOTECH INC. THIS PRODUCT
IS LICENSED FOR SALE ONLY FOR RESEARCH.
IT IS NOT LICENSED FOR ANY OTHER USE.
THERE IS NO IMPLIED LICENSE HEREUNDER FOR ANY COMMERCIAL USE.
COMMERCIAL USE shall include:
1.
Sale, lease, license or other transfer of the material or any material derived or produced from it.
2.
Sale, lease, license or other grant of rights to use this material or any other material derived
or produced from it
3.
Use of this material to perform services for a fee for third parties.
IF YOU REQUIRE A COMMERCIAL LICENSE TO USE THIS MATERIAL AND DO NOT HAVE ONE,
RETURN THIS MATERIAL, UNOPENED TO eBioscience AND ANY MONEY PAID FOR THE
MATERIAL WILL BE REFUNDED.